Publicações

AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

AuthID
P-00Q-938

Author(s)

Leonard, JP

Trneny, M

Izutsu, K

Fowler, NH

Hong, XN

Zhu, J

Zhang, HL

Offner, F

Scheliga, A

Nowakowski, GS

[+1]·

Re, F

Fogliatto, LM

Scheinberg, P

Flinn, IW

Moreira, C

Liu, D

Kalambakas, S

Fustier, P

Wu, CQ

Gribben, JG

View all authors

Tipo de Documento

Abstract

Year published

2018

Publicado

in BLOOD, ISSN: 0006-4971

Volume: 132

Conference

60Th Annual Meeting of the American-Society-Of-Hematology (Ash), Date: DEC 01-04, 2018, Location: San Diego, CA, Patrocinadores: Amer Soc Hematol

Indexing

Wos^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1182/blood-2018-99-110861

Wos: WOS:000454837601154

Source Identifiers

ISSN: 0006-4971

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Leonard, JP;	2	Trneny, M;	3	Izutsu, K;
4	Fowler, NH;	5	Hong, XN;	6	Zhu, J;
7	Zhang, HL;	8	Offner, F;	9	Scheliga, A;
10	Nowakowski, GS;	11	Pinto, A;	12	Re, F;
13	Fogliatto, LM;	14	Scheinberg, P;	15	Flinn, IW;
16	Moreira, C;	17	Liu, D;	18	Kalambakas, S;
19	Fustier, P;	20	Wu, CQ;	21	Gribben, JG;

AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

AUGMENT: A Phase Iii Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Links Úteis

Ajuda